Our quality product service solutions bridge the gaps between technology and patient care by providing custom-tailored cell therapy services, including:
2007 September 17 -- MicroIslet and Progenitor Cell Therapy Enter Into Agreement for the Manufacturing of MicroIslet-P, an Encapsulated Islet Cell Product for the Treatment of Type 1 Diabetes. SAN DIEGO and HACKENSACK, N.J. (PRIME NEWSWIRE)